Insilico Medicine announces launch of intelligently-formulated nutraceuticals in Europe

Insilico Medicine, Inc, a big data analytics company applying latest advances in deep learning to drug discovery, biomarker development, and aging research today announced that the line of nutraceuticals developed in collaboration with Life Extension will be available across Europe.

About the author

Alexis Anderson

View all posts

Leave a Reply

Your email address will not be published. Required fields are marked *